XW143YBTransfusion of Nonautologous (Human) Fibrinogen Concentrate, Shelf-stable into Central Vein, Percutaneous Approach, New Technology Group 11

New Technology›Anatomical Regions›Transfusion
ICD-10-PCS XW143YB
CMS Source: FY 2026 ICD-10-PCS dataset. Effective Oct 1, 2025 – Sep 30, 2026.FacebookXLinkedInPrint

XW143YB is a billable ICD-10-PCS procedure code for Transfusion of Nonautologous (Human) Fibrinogen Concentrate, Shelf-stable into Central Vein, Percutaneous Approach, New Technology Group 11. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The root operation Transfusion involves putting in blood or blood products.

Code Identity

ICD-10-PCS Code
XW143YB
Billable Status
Yes — Valid for Submission
Code Describes
Transfusion of Nonautologous (Human) Fibrinogen Concentrate, Shelf-stable into Central Vein, Percutaneous Approach, New Technology Group 11
Parent Code
XW1
Short Description
Transfuse Fibrgn Shf-stbl in Central Vein, Perc, New Tech 1

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

PositionDesignationValueMeaning
1SectionXNew Technology
2Body SystemWAnatomical Regions
3Operation1Transfusion
4BodyPart4Central Vein
5Approach3Percutaneous
6Device/Substance/TechnologyYNonautologous (Human) Fibrinogen Concentrate, Shelf-stable
7QualifierBNew Technology Group 11

Code History

FY 2026New code, effective October 1, 2025.
Replaces previously assigned code(s):
  • 30243T1 — Transfuse Nonaut Fibrinogen in Central Vein, Perc

Similar Procedure Codes

Questions About XW143YB

Is XW143YB a billable code?

Yes. XW143YB is a complete seven-character ICD-10-PCS code, specific enough to report Transfusion of Nonautologous (Human) Fibrinogen Concentrate, Shelf-stable into Central Vein, Percutaneous Approach, New Technology Group 11 on inpatient claims from October 1, 2025 through September 30, 2026.

What do the characters in XW143YB mean?

XW143YB breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character W is the Body System (Anatomical Regions); the 3rd character 1 is the Operation (Transfusion); the 4th character 4 is the BodyPart (Central Vein); the 5th character 3 is the Approach (Percutaneous); the 6th character Y is the Device/Substance/Technology (Nonautologous (Human) Fibrinogen Concentrate, Shelf-stable); the 7th character B is the Qualifier (New Technology Group 11).